ZBH Zimmer Biomet

Q3 2025 10-Q

Filed: Nov 5, 2025Period ending Sep 30, 2025

Health Care

Orthopedic, Prosthetic & Surgical Appliances & SuppliesSEC EDGAR

Zimmer Biomet (ZBH) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue $2.001B Q3 2025, up 9.7% vs $1.824B Q3 2024; Nine months $5.988B, up 5.9% vs $5.655B 2024
• Operating profit margin Q3 17.6% vs 15.3% YoY; Nine months 15.8% vs 15.9% YoY (slight decrease)

+3 more insights

Risk Factors

• No new or changed risk factors since 2024 Form 10-K disclosed in this 10-Q
• Continued exposure to product liability and regulatory compliance risks from medical device industry regulations

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$2.0B

▲ +9.7% YoY▼ -3.7% QoQ

Net Income

$231M

▼ -7.3% YoY▲ +51.0% QoQ

Net Margin

11.5%

▼ -212bp YoY▲ +418bp QoQ

Source: XBRL data from Zimmer Biomet Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Zimmer Biomet Quarterly Reports

Q1 2025 10-Q

Get deeper insights on Zimmer Biomet

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.